These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 29776842)
1. [Risk of axillary recurrence after sentinel lymph node biopsy before neoadjuvant chemotherapy in breast cancer]. Tardieu A; Mesnard C; Margueritte F; Mollard J; Lacorre A; Aubard Y; Deluche E; Gauthier T Gynecol Obstet Fertil Senol; 2018 Jun; 46(6):509-513. PubMed ID: 29776842 [TBL] [Abstract][Full Text] [Related]
2. Long-Term Follow-Up of Node-Negative Breast Cancer Patients Evaluated via Sentinel Node Biopsy After Neoadjuvant Chemotherapy. Nogi H; Uchida K; Mimoto R; Kamio M; Shioya H; Toriumi Y; Suzuki M; Nagasaki E; Kobayashi T; Takeyama H Clin Breast Cancer; 2017 Dec; 17(8):644-649. PubMed ID: 28601382 [TBL] [Abstract][Full Text] [Related]
3. [Assessment of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy in breast cancer: before or after?]. Coutant C; Jankowski C; Portha H; Barranger E Gynecol Obstet Fertil; 2016 Jun; 44(6):345-9. PubMed ID: 27234216 [TBL] [Abstract][Full Text] [Related]
4. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy. Navarro-Cecilia J; Dueñas-Rodríguez B; Luque-López C; Ramírez-Expósito MJ; Martínez-Ferrol J; Ruíz-Mateas A; Ureña C; Carrera-González MP; Mayas MD; Martínez-Martos JM Eur J Surg Oncol; 2013 Aug; 39(8):873-9. PubMed ID: 23711734 [TBL] [Abstract][Full Text] [Related]
5. Advantages of preoperative localization and surgical resection of metastatic axillary lymph nodes using magnetic seeds after neoadjuvant chemotherapy in breast cancer. Mariscal Martínez A; Vives Roselló I; Salazar Gómez A; Catanese A; Pérez Molina M; Solà Suarez M; Pascual Miguel I; Blay Aulina L; Ríos Gozálvez C; Julián Ibáñez JF; Rodríguez Martínez P; Martínez Román S; Margelí Vila M; Luna Tomás MA Surg Oncol; 2021 Mar; 36():28-33. PubMed ID: 33285433 [TBL] [Abstract][Full Text] [Related]
6. The Shift From Sentinel Lymph Node Biopsy Performed Either Before or After Neoadjuvant Systemic Therapy in the Clinical Negative Nodes of Breast Cancer Patients. Results, and the Advantages and Disadvantages of Both Procedures. Fernandez-Gonzalez S; Falo C; Pla MJ; Pernas S; Bajen M; Soler T; Ortega R; Quetglas C; Perez-Martin X; Fernandez Montoli ME; Campos M; Varela-Rodriguez M; Ponce J; Garcia-Tejedor A Clin Breast Cancer; 2018 Feb; 18(1):71-77. PubMed ID: 29030106 [TBL] [Abstract][Full Text] [Related]
7. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes. Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919 [TBL] [Abstract][Full Text] [Related]
8. [Sentinel lymph node biopsy and neoadjuvant treatment in breast cancer]. Duraes M; Guillot E; Seror J; Pouget N; Rouzier R Bull Cancer; 2017 Oct; 104(10):892-901. PubMed ID: 28890124 [TBL] [Abstract][Full Text] [Related]
9. Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer. Park S; Lee JE; Paik HJ; Ryu JM; Bae SY; Lee SK; Kim SW; Nam SJ Clin Breast Cancer; 2017 Feb; 17(1):e19-e29. PubMed ID: 27495997 [TBL] [Abstract][Full Text] [Related]
10. Axillary and internal mammary sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. Cao XS; Li HJ; Cong BB; Sun X; Qiu PF; Liu YB; Wang CJ; Wang YS Oncotarget; 2016 Nov; 7(45):74074-74081. PubMed ID: 27738336 [TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fine needle aspiration. Yu Y; Cui N; Li HY; Wu YM; Xu L; Fang M; Sheng Y BMC Cancer; 2016 Oct; 16(1):808. PubMed ID: 27756234 [TBL] [Abstract][Full Text] [Related]
12. A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer. Kida K; Ishikawa T; Yamada A; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I Eur J Surg Oncol; 2015 Apr; 41(4):566-70. PubMed ID: 25650249 [TBL] [Abstract][Full Text] [Related]
13. Management of the Axilla After Neoadjuvant Chemotherapy: Can Axillary Needle Biopsy Replace Sentinel Node Biopsy? Yildirim E; Basim P; Ucar N; Bektas S; Iscen K; Karci E; Ozdemir AA In Vivo; 2024; 38(5):2523-2530. PubMed ID: 39187354 [TBL] [Abstract][Full Text] [Related]
14. Neo-adjuvant chemotherapy and axillary de-escalation management for patients with clinically node-negative breast cancer. Shi ZQ; Qiu PF; Liu YB; Cong BB; Zhao T; Chen P; Wang CJ; Zhang ZP; Sun X; Wang YS Breast J; 2019 Nov; 25(6):1154-1159. PubMed ID: 31332886 [TBL] [Abstract][Full Text] [Related]
15. Refining the Performance of Sentinel Lymph Node Biopsy Post-neoadjuvant Chemotherapy in Patients with Pathologically Proven Pre-treatment Node-positive Breast Cancer: An Update for Clinical Practice. El Hage Chehade H; Headon H; Kasem A; Mokbel K Anticancer Res; 2016 Apr; 36(4):1461-71. PubMed ID: 27069121 [TBL] [Abstract][Full Text] [Related]
16. A Novel Less-invasive Approach for Axillary Staging After Neoadjuvant Chemotherapy in Patients With Axillary Node-positive Breast Cancer by Combining Radioactive Iodine Seed Localization in the Axilla With the Sentinel Node Procedure (RISAS): A Dutch Prospective Multicenter Validation Study. van Nijnatten TJA; Simons JM; Smidt ML; van der Pol CC; van Diest PJ; Jager A; van Klaveren D; Kam BLR; Lobbes MBI; de Boer M; Verhoef K; Koppert LB; Luiten EJT Clin Breast Cancer; 2017 Aug; 17(5):399-402. PubMed ID: 28487053 [TBL] [Abstract][Full Text] [Related]
17. Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer. Yagata H; Yamauchi H; Tsugawa K; Hayashi N; Yoshida A; Kajiura Y; In R; Matsuda N; Nakamura S Clin Breast Cancer; 2013 Dec; 13(6):471-7. PubMed ID: 24267732 [TBL] [Abstract][Full Text] [Related]
18. Enhanced Axillary Evaluation Using Reflector-Guided Sentinel Lymph Node Biopsy: A Prospective Feasibility Study and Comparison With Conventional Lymphatic Mapping Techniques. Taback B; Jadeja P; Ha R Clin Breast Cancer; 2018 Oct; 18(5):e869-e874. PubMed ID: 29544701 [TBL] [Abstract][Full Text] [Related]
19. Wang J; Fan T; He Y; Chen X; Fan Z; Xie Y; Wang T; Li J; Ouyang T Breast Cancer Res Treat; 2018 Apr; 168(2):365-370. PubMed ID: 29209873 [TBL] [Abstract][Full Text] [Related]
20. Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy. Kang YJ; Han W; Park S; You JY; Yi HW; Park S; Nam S; Kim JH; Yun KW; Kim HJ; Ahn SH; Park S; Lee JE; Lee ES; Noh DY; Lee JW Breast Cancer Res Treat; 2017 Nov; 166(2):473-480. PubMed ID: 28766131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]